参考文献/References:
[1] Jadvar H,Connolly LP,Fahey FH,et al.PET and PET/CT in pediatric oncology.Semin Nucl Med,2007,37(5):316-331.
[2] Gelfand MJ,Lemen LC.PET/CT and SPECT/CT dosimetry in children:The challenge to the pediatric imager.Semin Nucl Med,2007,37(5):391-398.
[3] Hahn K.Pfluger T.Is PET/CT necessary in paediatric oncolngy? Against.Eur J Nucl Med Mol Imaging,2006,33(8):966-968.
[4] Munson S,Eshel N,Ernst M,et al.Ethics of PET research in children//charron M.Pediatric PET imaging.New York:Springer New York,2006:72-91.
[5] Nanni C,Rubello D,CasteUueci P,et al.18F-FDG PET/CT fusion imaging in pediatric solid extracranial turnouts.Biomed Pharnmacother,2006,60(9):593-606.
[6] Wegner EA,Barrington SF,Kingston JE,et al.The impact of PET scanning on management of pediatric oncology patients.Eur J Nucl Med Mol Imaging,2005,32(1):23-30.
[7] Kabickova E,Sumeraner D,Cumlivska E,et al.Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin’s disease.Eur Nucl Med Mol Imaging,2006,33(9):1025-1031.
[8] Miller E,Metser U,Avrahami G,et al.Role of 18F-FDG PET/CT in staging and follow-up of lymphoma in pediatric and young adult patients.J Comput Assist Tomogr,2006,30(4):689-694.
[9] Certh HU,Juergens KU,Dirkson U,et al.Significant benefit of multimodal imaging:PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumors.J Nucl Med,2007,48(12):1932-1939.
[10] Liuabery AM,Ross JA.Trends in childhood cancer incidence in the U.S.(1992-2004).Cancer,2008,112(2):416-432.
[11] Tatsumi M,Miller JH,Wahl RL.18F-FDG PET/CT in evaluating non-CNS pediatric malignancies.J Nucl Med,2007,48(12):1923-1931.
[12] Rhodes MM,Delbeke D,Whitlock JA,et al.Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma-J Pediatr Hematol Oncol,2006,28(5):300-306.
[13] Patil S,Biassoni L,Borgwardt L Nuclear medicine in pediatric neurology and neurosurgery:epilepsy and brain tumors.Semin Nucl Med,2007,37(5):357-381.
[14] Ishola TA,Chung DH.Neuroblastoma.Surg Oncol,2007,16(3):149-156.
[15] Maris JM,Hogarty MD,Bagatell R.et al.Neuroblastoma.Lancet,2007,369(9579):2106-2120.
[16] Federman N,Feig SA.PET/CT in evaluating pediatric malignancies:a clinician’s perspective.J Nucl Med,2007,48(12):1920-1922.
[17] Chawla M,NC,Agarwala S,et al.Serial renal dynamic scintigraphy in evaluation of renal function in patient with bilateral Wilms’ tumors.Clin Nucl Med,2005,30(12):820-822.
[18] McLean TW,Castellino SM.Pediatric genitourinary tumors.Curr Opin Oncol,2008,20(3):315-320.
[19] Misch D,Steffen IG,Schonberger S,et al.Use of positron emission temography for staging,preoperative response assessment and posttherapeutic evaluation in children with Wilms tumour.Eur J Nucl Med Mol Imaging,2008,35(9):1642-1650.
[20] Leaphart C,Rodeberg D.Pediatric surgical ontology:management of rhabdomyosarcoma.Surg Oncol,2007,16(3):173-185.
[21] Klem ML,Grewal RK,Wexler LH,et al.PET for staging in rhabdornyosarcoma:an evaluation of PET as an adjunct to current staging tools.J Pediatr Hematol Oncol,2007,29(1):9-14.
[22] Peng F,Rabkin G,Muzik O.Use of 2-doxy-2-[F-18]-fluoro-Dglucose positron emission tomography to monitor therapeutic response by rhabdomyosareoma in children:report of a retrospective case study.Clin Nucl Med,2006,31(7):394-397.
相似文献/References:
[1]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[2]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[3]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[4]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[5]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[6]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[7]张巧娜,刘汉东.上颌窦上皮-肌上皮癌的CT表现一例[J].国际放射医学核医学杂志,2016,40(3):237.[doi:10.3760/cma.j.issn.1673-4114.2016.03.015]
[8]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[9]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[10]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[11]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[12]吴冰,石洪成.18F-FDG PET-CT在胰腺癌诊治中的应用[J].国际放射医学核医学杂志,2011,35(4):234.[doi:10.3760/cma.j.issn.1673-4114.2011.04.010]
WU Bing,SHI Hong-cheng.18F-FDG PET-CT for the clinical application of pancreatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):234.[doi:10.3760/cma.j.issn.1673-4114.2011.04.010]